UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation

Pediatric pulmonology, 2020-06, Vol.55 (6), p.1400-1405

2020

Volltextzugriff (PDF)

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes

Journal of cystic fibrosis, 2023-05, Vol.22 (3), p.548-559

2023

Volltextzugriff (PDF)

418 The CCFR-cohort: a longitudinal cohort integrating care, research and in-vitro data of CF-patients

Journal of cystic fibrosis, 2017-06, Vol.16, p.S169-S169

2017

Volltextzugriff (PDF)

WS12.4 The predictive value of oral glucose tolerance for the development of CFRD in CF children: a longitudinal study

Journal of cystic fibrosis, 2016-06, Vol.15, p.S20-S20

2016

Volltextzugriff (PDF)

WS18.2 The rainbow project: personalised medicine for CF-patients with rare mutations

Journal of cystic fibrosis, 2017-06, Vol.16, p.S30-S30

2017

Volltextzugriff (PDF)

29 Validating the organoid model across European laboratories

Journal of cystic fibrosis, 2017-06, Vol.16, p.S70-S71

2017

Volltextzugriff (PDF)

23 Stratifying young children with cystic fibrosis for disease severity using intestinal organoid swelling, intestinal current measurements or sweat chloride concentration as CFTR-dependent biomarker

Journal of cystic fibrosis, 2016-06, Vol.15, p.S57-S57

2016

Volltextzugriff (PDF)

24 Stratification for cystic fibrosis (CF) disease severity in adults with CF with homozygous F508del mutations by intestinal organoids

Journal of cystic fibrosis, 2016-06, Vol.15, p.S57-S57

2016

Volltextzugriff (PDF)

WS18.2 Prospective selection of potential CFTR-modifying treatments using intestinal organoids

Journal of cystic fibrosis, 2016-06, Vol.15, p.S29-S30

2016

Volltextzugriff (PDF)

665: Forskolin-induced intestinal organoid swelling predicts long-term cystic fibrosis disease progression

Journal of cystic fibrosis, 2021-11, Vol.20, p.S315

2021

Volltextzugriff (PDF)

P353 The effects of ivacaftor on resting energy expenditure, exercise capacity, and body composition in patients with cystic fibrosis, heterozygous for a S1251N mutation

Journal of cystic fibrosis, 2019-06, Vol.18, p.S157-S158

2019

Volltextzugriff (PDF)

ePS1.04 In vivo effect of three potentiator treatments found effective in rectal organoids

Journal of cystic fibrosis, 2019-06, Vol.18, p.S40-S40

2019

Volltextzugriff (PDF)

Angular Gyrus Involvement at Encoding and Retrieval Is Associated with Durable But Less Specific Memories

The Journal of neuroscience, 2017-09, Vol.37 (39), p.9474-9485

2017

Volltextzugriff (PDF)

Bridging the gap: advancing cancer cell culture to reveal key metabolic targets

Frontiers in oncology, 2024-09, Vol.14, p.1480613

2024

Volltextzugriff (PDF)

Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37

Nature communications, 2022-09, Vol.13 (1), p.5371-5371, Article 5371

2022

Volltextzugriff (PDF)

An adaptive function of mental time travel: Motivating farsighted decisions

The Behavioral and brain sciences, 2018, Vol.41, p.e3-e3, Article e3

2018

Volltextzugriff (PDF)

Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity

Immunity (Cambridge, Mass.), 2013-08, Vol.39 (2), p.259-271

2013

Volltextzugriff (PDF)

Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules

The Journal of immunology (1950), 2015-11, Vol.195 (9), p.4085-4095

2015

Volltextzugriff (PDF)

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

Cancer cell, 2005-11, Vol.8 (5), p.407-419

2005

Volltextzugriff (PDF)

Degree of Skin Barrier Disruption Affects Lipid Organization in Regenerated Stratum Corneum

Acta dermato-venereologica, 2018-01, Vol.98 (4), p.421-427

2018

Volltextzugriff (PDF)

Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients

Frontiers in immunology, 2020-05, Vol.11, p.822

2020

Volltextzugriff (PDF)

Innate Immune Training of Human Macrophages by Cathelicidin Analogs

Frontiers in immunology, 2022-07, Vol.13, p.777530-777530

2022

Volltextzugriff (PDF)

Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers

Nature communications, 2022-08, Vol.13 (1), p.4578-19, Article 4578

2022

Volltextzugriff (PDF)

Transient medial prefrontal perturbation reduces false memory formation

Cortex, 2017-03, Vol.88, p.42-52

2017

Volltextzugriff (PDF)

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Cell reports (Cambridge), 2019-02, Vol.26 (7), p.1701-1708.e3

2019

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation

FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes

418 The CCFR-cohort: a longitudinal cohort integrating care, research and in-vitro data of CF-patients

WS12.4 The predictive value of oral glucose tolerance for the development of CFRD in CF children: a longitudinal study

WS18.2 The rainbow project: personalised medicine for CF-patients with rare mutations

29 Validating the organoid model across European laboratories

23 Stratifying young children with cystic fibrosis for disease severity using intestinal organoid swelling, intestinal current measurements or sweat chloride concentration as CFTR-dependent biomarker

24 Stratification for cystic fibrosis (CF) disease severity in adults with CF with homozygous F508del mutations by intestinal organoids

WS18.2 Prospective selection of potential CFTR-modifying treatments using intestinal organoids

665: Forskolin-induced intestinal organoid swelling predicts long-term cystic fibrosis disease progression

P353 The effects of ivacaftor on resting energy expenditure, exercise capacity, and body composition in patients with cystic fibrosis, heterozygous for a S1251N mutation

ePS1.04 In vivo effect of three potentiator treatments found effective in rectal organoids

Angular Gyrus Involvement at Encoding and Retrieval Is Associated with Durable But Less Specific Memories

Bridging the gap: advancing cancer cell culture to reveal key metabolic targets

Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37

An adaptive function of mental time travel: Motivating farsighted decisions

Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity

Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

Degree of Skin Barrier Disruption Affects Lipid Organization in Regenerated Stratum Corneum

Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients

Innate Immune Training of Human Macrophages by Cathelicidin Analogs

Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers

Transient medial prefrontal perturbation reduces false memory formation

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Suchergebnisse filtern